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ABSTRACT 
 
Postprandial hyperglycemia is triggered by two enteric proteins (α-amylase and α-
glucosidase) connected to the brush border of intestinal cells. In diabetic populations, Type 2 
Diabetes Mellitus is more prevalent, and α-glucosidase inhibition is the suitable therapy for 
delaying glucose intake after meals. This study was designed to investigate chemical compounds 
for their potential inhibitory effects on α-glucosidase. It employed a spectrophotometric method 
with p-nitrophenyl-α-D-glucopyranose from Saccharomyces cerevisiae as an alpha-
glucosidase substrate. The ethanolic fraction was acquired from assay- or activity-guided 
fractionation. The findings showed that the ethanolic fraction of soursop leaves exhibited the most 
significant inhibitory activity with an IC50 of 0.17 μg/mL. The data analysis and active compounds 
identification were carried out by LC-MS and FT-IR. The active compounds of the resulted 
mixture comprised of  Muricatin C, cis-Reticulatacin-10-one, and 3-Methylquercetin 7-[galactosyl-
(1->4)-glucoside]. 
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INTRODUCTION 
Diabetes is a chronic metabolic disorder signified by high blood glucose levels due to 
insufficient endogenous insulin production from pancreatic beta cells (type 1 diabetes) or impaired 
insulin secretion and activity (type 2 diabetes). Type 1 diabetes is an autoimmune disorder defined 
by pancreatic beta-cell dysfunction, whereas type 2 diabetes refers to a gradual increase in 
resistance and beta-cell dysfunction firmly associated with obesity and lifestyle (Zimmet, 2001). 
Due to the high incidence of its risk factors, the prevalence of diabetes in developing nations is 
growing globally and more pronounced. Current estimates show that the illness affects a broader 
group of adolescents by 69% from 2010 to 2030, which is considerably higher compared to 20% in 
developed nations (Shaw, 2010).  
Glucose metabolism dysfunction is strongly linked to impaired insulin secretion because it 
creates abnormal levels of plasma glucose. Increased abnormal blood glucose in metabolic diseases 
is pathogenic (Mugiyanto, 2017). Postprandial hyperglycemia, also known as Glucose Tolerance 
Disorder (GTG), is a glucose regulatory phase in people with glucose tolerance above the standard 
range but below the level of type 2 diabetes. GTG is a transitional phase between normal glucose 
tolerance and type 2 DM. Postprandial hyperglycemia plays a key role in developing diabetic 
complications, particularly cardiovascular disease. A rapid and substantial increase in glycemia 
typifies the postprandial phase (Ceriello, 2005). 
One of the fundamental considerations in postprandial hyperglycemia is rapid glucose intake in 
the intestine, where α-glucosidase hydrolyzes starch and oligosaccharides (Quezada-Calvillo, 
2007). α-glucosidase is an enzyme present in the intestinal brush border responsible for 
breakdowns of oligosaccharides (e.g., maltose, maltotriose, and dextrin) that produce 
monosaccharides (e.g., glucose, galactose, and fructose), which are rapidly absorbed in the small 
intestinal wall. Consequently, to suppress α-glucosidase activity is the recommended approach for 
the management of postprandial hyperglycemia (Borges de Melo, 2006). 
Diabetes management uses three groups of drugs. The first group is sulfonylureas, such as 
glibenclamide, glinides, insulin analogs, glucagon-like peptide 1 (GLP-1), and dipeptidyl 
peptidase-IV (DPP-IV) inhibitors, which promote the accessibility of endogenous insulin belonging 
to this group. The first two group members are pancreatic sulfonylurea receptors that boost the 
secretion of insulin. On the other side, GLP-1 agonists and DPP-IV inhibitors operate on tiny 
intestine ileal cells. The second group raises the sensitivity of insulin, including 
thiazolidinediones―i.e., agonists of the Peroxisome proliferator-activated gamma receptor (PPAR) 
and biguanide-methane. The third group is made up of α-glucosidase inhibitors like acarbose, 
which operates by decreasing the digestion and bioavailability of polysaccharides (Chehade, 2000). 
All available therapies have limited efficacy, restricted tolerability, specific side effect 
mechanisms, or the combination thereof (Moller, 2001). 
The World Health Organization (WHO) claims that more than 80% of the world's total 
population depend on traditional medicines. It also acknowledges that traditional medicines are not 
only a therapy that is accessible and affordable but also a culture that many local individuals 
believe. It exists as an almost universal behavior to suppress the development of chronic non-
infectious disorders amid the rising health and hygiene expenses (Anonymous, 2008). Vegetable 
crops and medicinal products are currently the basis of many contemporary medicinal products for 
treating different illnesses. The significance of natural products for drug discovery in the future is 
evident: new pharmacologically active natural products will continue to support as lead compounds 
for drug development and are biochemical markers for pharmacological and biochemical process 
discovery (Soumya, 2009). 
Soursop (Annona muricata), locally known as asguanabana, graviola, Zuurzak, sirsak, 
coração-da-India, guyabano, or corossol, is an exotic and delicious fruit that is very popular in 
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tropical Asia today. It originated in the West Indies, Central America, and Brazil. More than 50 
mono-THF acetogenins have been discovered in the seeds and leaves of this species. Recently, 
some of the main intermediates involved in the biosynthesis of acetogenin have been separated 
from this species and are known as epomuricenins-A and B, montecristin, cohibins-A and B, 
pupin-1 and 2, pupin-3 and 4, muricadienin, and chatenaytrienins-1, 2, and 3, as well as a novel 
compound called sabadelin, a potentially biogenetic precursor for cis-panatellin (Ivan, 2003). 
Annona muricata is a medicinal plant used as a natural remedy for multiple health 
conditions. Several studies have shown that A. muricata bark and leaf have anti-hypertensive, 
vasodilatory, and anti-spasmodic (muscle relaxing) activities and cardiovascular effects that slow 
heart rate. Other properties and activities of A. muricata have been documented through its 
traditional use as anticancer, antibacterial, antifungal, antimalarial, antimutagenic (cellular 
protectors), and anticonvulsant, as well as vomiting and uterine stimulants and insecticides. It is 
also believed to stimulate digestion, be effective for cardiovascular antiviral (to strengthen the 
heart), febrifuge (to cure fever), vermifuge, pediculicide, and analgesics, and promote proper 
functioning of the nervous system. Padma et al. (1998) confirm that the ethanolic extract of A. 
muricata has antiviral effects against Herpes simplex virus. A. muricata extract has been reported 
to exhibit antiparasitic, antirheumatic, astringent, antileishmanial, and cytotoxic effects. A. 
muricata has also been proven effective against multi-drug resistance (MDR) in cancer cells 
(Oberlies, 1997). It has been used as medicinal herbs in many parts of the globe where there is 
traditionally restricted access to formal healthcare. There are several reasons why the use of 
medicinal plants should be studied. Among which is the potential for herbal remedies to have not 
only specific therapeutic effects but also toxic side effects (Bailey and Day, 1989). 
One method to relieve metabolic disorders in people with diabetes includes taking 
hypoglycemic oral synthetic drugs. However, long-term use will trigger side effects such as acute 
hypoglycemia, kidney damage, liver damage, and lactic acidosis (Murray, 2003). Therefore, the use 
of natural products as natural anti-diabetic drugs seems to be an increased preference among 
society. Although there have been many previous studies of soursop as an α-glucosidase inhibitor, 
the focus remains on assessing the activity of the extract instead of identifying the active fractions 
or compounds responsible for the activity. Therefore, in this research, the compounds that inhibit α-
glucosidase enzyme have been identified. 
 
METHOD 
This experimental study was designed to identify which active compound of the secondary 
metabolite in A. muricata leaf has α-glucosidase inhibitor property. 
 
Material 
A. muricata used in this research was from the Jogjakarta region and was confirmed in the 
herbarium laboratory (LIPI) in Bogor, Indonesia. Acarbose, alpha-glucosidase, and p-NPG were 
purchased from Sigma-Aldrich. The experiment used the instruments for Fourier Transform-
Infrared Spectroscopy (FTIR, Shimadzu IR Prestige 21) and Mass Spectrometry-Liquid 
Chromatography (LC-MS, Mariner Biospectrometry). 
The extraction employed a multilevel maceration technique with several solvents and water 
infusions. Soursop leaf powder was obtained with n-hexane, ethyl acetate, 96 %ethanol, and water. 
The produced filtrate was evaporated and calculated to measure the percentage of the outcome. 
Afterward, the ethanolic extract was fractionated by silica gel column chromatography using the 
eluent CH2Cl2-MeOH with a ratio of (20:1) to (1:1). The fraction exhibiting the highest inhibitory 
activity against α-glucosidase was purified by preparative TLC, resulting in isolates that were 
further identified by IR spectra and LC-MS. 
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The α-glucosidase assay was prepared following the procedure introduced in Oki et al. 
(1999) with few modifications. As for the inhibitory activity assay, it was based on the reaction of 
α-glucosidase to the substrate p-nitrophenyl-α-D-glucopyranoside (p-NPG). A total of 250 μL 
sample with various concentrations were added with 250 μL of p-NPG and then incubated at 37°C 
for 5 minutes. Afterward, the sample was added with 250 μL of the α-glucosidase enzyme and 
incubated at 37°C for 15 minutes. After the incubation, the sample was added with 500 μL of 
Na2CO3 to stop enzymatic reaction. The absorbance was measured in a UV-Vis spectrophotometer 
at a wavelength of 413 nm. The formula and procedure of the experiment are presented in Table I. 
 
Table I.  The assay system to evaluate the inhibitory activities against α-glucosidase 
 
 
Blank 
(µL) 
B1 
Blank 
Control 
(µL) 
B0 
Sample 
(µL) 
S1 
Sample 
Control (µL) 
S0 
Sample - - 250 250 
p-NPG 250 500 250 250 
Phosphate buffer 250 250 - 250 
Incubation at 37
o
C for 5 minutes 
Enzyme 250 - 250 - 
Na2CO3 - 500 - 500 
Incubation at 37
o
C for 15 minutes 
Na2CO3 500 - 500 - 
 
Data Analysis 
Each fraction of the assay was subjected to inhibitory activity test. The absorbances of the 
blank solution, positive control, and the test solution were measured in a UV-Vis 
spectrophotometer and then calculated to find the percentage of (antidiabetic) inhibitory activity 
using the formula below: 
%𝐼𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =
𝐶 − 𝑆
𝑆
× 100% 
 
where: 
 C = Absorbance of (Blank (B1) - Control Blank (B0)) 
 S = Absorbance of (S1 - S0)  
 
RESULTS AND DISCUSSION 
α-glucosidase belongs to the glycoside hydrolases (GHs) family, which catalyzes the 
degradation of the glycosidic bond by the retaining or inverting mechanisms of anomeric 
configuration (Koshland, 2008). Stereochemical inversion of an anomeric position involves a 
single-step mechanism in which protonation of glycosidic oxygen by acids and clusters are 
accompanied by a nucleophilic attack of a deprotonated water molecule by bases. Typically, acid 
and base residues are carboxylic groups of enzymes. 
The Annona muricata leaf extract was subjected to α-glucosidase inhibition assay. The 
inhibitory properties of the infusions and the hexane, acetate ethyl, ethanolic, and water extracts of 
soursop leaf are presented in Table II. 
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Table II. The results of the α-glucosidase assay of extracts and infusions of Annona muricata 
Extracts IC50 (ppm) 
n-hexane extract 67.53 ± 3.26 
Acetate-Ethyl extract 277.62 ± 17.92 
Ethanolic extract 63.73 ± 4.11 
Water extract 1682.76 ± 67.45 
Infusion 1934.87 ± 91.33 
 
Afterward, column chromatography was performed until a single active compound was 
found (Table III.). 
Table III The α-glucosidase assay of Annona muricata isolates 
Fractions IC50 (ppm) 
Isolate I 16.20 ± 0.72 
Isolate II 0.76 ± 0.03 
Isolate III 0.17 ± 0.02 
Acarbose 0.004 ± 0.0008 
 
Isolate III was a solid yellow powder with the lowest IC50. The compound was identified by 
LC-MS with dichloromethane-methanol (20:1) as the eluent that flowed down through the column 
at a speed of 1 mL/min 
.  
 
Figure 1. The LC-MS Spectrum of Isolate III Mobile phase: dichloromethane-methanol, 20:1 ratio, at 
a rate of 1 ml/minute  
 
The LC-MS chromatogram showed that isolate III was not a pure compound because the spectrum 
had three peaks,  as shown in Figure. 1. The m/z values for each peak are listed in Table IV. 
 
Each pattern of the LC-MS chromatogram was contrasted with a similar fragmentation 
pattern of known compounds of A. muricata L. 
 
Table IV. The m/z values of the three peaks of isolate III  
Peaks of 
Isolate 
III 
Rt m/z (M+H) 
1 
2 
3 
5.00 
6.17 
7.15 
639 
607 
641 
At Rt=5.00 min, the compound had a molecular weight (MW) of 638 amu, A scientific 
literature (Anonymous, 2016) suggests that there are two recognized compounds with an MW of 
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638 amu,  namely purpurenin and Muricatin C. Then, the fragmentation pattern of isolate III was 
compared to  that of purpurenin and Muricatin C, as depicted in the literature (Figure 2). 
 
 
 
Figure 2. The MS Fragmentation of Isolate III at Rt=5.00 min Fragmentation type: positive (M+H) 
 
The comparison between the fragmentation patterns of the suspected compounds in Isolate 
III and the reference compounds (from the literature) showed a match with Muricatin C (acetogenin 
class). The molecular formula of this compound is C37H66O8, with the chemical structure displayed 
in Figure 3. 
 
Figure 3. The Chemical Structure of Muricatin C 
 
The MS spectrum at Rt=6.17 min indicates the m/z value of 607 (M+H) as the base peak, 
from which an MW of 606 amu was obtained. Then, the MS fragmentation pattern of isolate III at 
this retention time was compared to that of the reference compound (Anonymous, 2016) (Figure 4). 
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Figure 4. The MS Fragmentation of Isolate III at Rt=6.17 min Fragmentation type: positive (M+H) 
 
At Rt=6.17 min, the suspected compound was cis-Reticulatacin-10-one, with a molecular 
formula of C37H66O6 and fragmentation patterns relatively similar to the reference. The chemical 
structure of the cis-Reticulatacin-10-one is showed in Figure 5. 
 
Figure 5. The Chemical Structure of cis-Reticulatacin-10-one 
 
The MS spectrum of Isolate III at Rt=7.51 min showed the m/z value of 641 (M+H) as the 
base peak, and a molecular weight (MW) of 640 amu was obtained. Then, any similarities in the 
fragmentation patterns of the suspected and reference compounds were observed (Figure 6.). 
 
Figure 6. The MS Fragmentation of Isolate III at Rt=7.51 min Fragmentation type: positive (M+H) 
 
At Rt=7.51 min, the suspected chemical compound was 3-Methylquercetin 7-[galactosyl-(1-
>4)-glucoside], which is a class of flavonoids with the molecular formula C28H32O17. The chemical 
structure is presented in Figure 7. 
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Figure 7. The Chemical Structure of 3-Methylquercetin 7-[galactosyl-(1->4)-glucoside] 
 
This study found that quercetin from the flavonoid group was an active compound in the test 
extracts. Flavonoids are common in crops and are a class of natural drugs with significant 
biological activity. There have been documents of their therapeutic potential against the 
development of diabetes and their reductive effects on diabetes (Srinivasan et al., 2005). Several 
publications on flavonoids as an α-glucosidase inhibitor have primarily addressed the inhibitory 
effects of different flavonoids on α-glucosidases and its structure-activity interactions (Tadera et 
al., 2006). 
 
CONCLUSION 
Isolates are not a single compound responsible for inhibitory activity against α-glucosidase 
(IC50=0.17 ppm). Identification of isolates by LC-MS has indicated that they are a mixture of 
several compounds. One isolate of Annona muricata had molecular weights of 638 amu at Rt=5.00 
min, 612 amu at Rt=6.17 min, and 640 amu at Rt=7.51 min. With these three characteristics, the 
suspected compounds are Muricatin C, cis-Reticulatacin-10-one, and 3-methyl quercetin 7-
[galactosyl-(1->4)-glucoside], respectively. 
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